ARCHIVES

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

In Brief: Florida Osteopaths Join Medical Examiners, Nullify State’s Law Supporting Laetrile

January 18, 1985

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974